Growth Metrics

United Health Products (UEEC) Equity Average (2016 - 2025)

United Health Products (UEEC) has disclosed Equity Average for 14 consecutive years, with -$3.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average fell 58.25% to -$3.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.3 million, a 58.25% decrease, with the full-year FY2024 number at -$2.1 million, down 10.03% from a year prior.
  • Equity Average was -$3.3 million for Q3 2025 at United Health Products, down from -$3.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of -$455994.5 in Q1 2021 to a low of -$3.3 million in Q3 2025.
  • A 5-year average of -$1.8 million and a median of -$1.9 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: surged 41.43% in 2021, then crashed 348.42% in 2022.
  • United Health Products' Equity Average stood at -$1.0 million in 2021, then tumbled by 89.5% to -$1.9 million in 2022, then increased by 8.21% to -$1.7 million in 2023, then tumbled by 30.26% to -$2.3 million in 2024, then crashed by 42.92% to -$3.3 million in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Equity Average are -$3.3 million (Q3 2025), -$3.0 million (Q2 2025), and -$2.6 million (Q1 2025).